Source author record

Joan Vila-Francés

Joan Vila-Francés appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
3topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2023arXiv

Empirical study of the modulus as activation function in computer vision applications

In this work we propose a new non-monotonic activation function: the modulus. The majority of the reported research on nonlinearities is focused on monotonic functions. We empirically demonstrate how by using the modulus activation function on computer vision tasks the models generalize better than with other nonlinearities - up to a 15% accuracy increase in CIFAR100 and 4% in CIFAR10, relative to the best of the benchmark activations tested. With the proposed activation function the vanishing gradient and dying neurons problems disappear, because the derivative of the activation function is always 1 or -1. The simplicity of the proposed function and its derivative make this solution specially suitable for TinyML and hardware applications.

preprint2015arXiv

Optimization of anemia treatment in hemodialysis patients via reinforcement learning

Objective: Anemia is a frequent comorbidity in hemodialysis patients that can be successfully treated by administering erythropoiesis-stimulating agents (ESAs). ESAs dosing is currently based on clinical protocols that often do not account for the high inter- and intra-individual variability in the patient's response. As a result, the hemoglobin level of some patients oscillates around the target range, which is associated with multiple risks and side-effects. This work proposes a methodology based on reinforcement learning (RL) to optimize ESA therapy. Methods: RL is a data-driven approach for solving sequential decision-making problems that are formulated as Markov decision processes (MDPs). Computing optimal drug administration strategies for chronic diseases is a sequential decision-making problem in which the goal is to find the best sequence of drug doses. MDPs are particularly suitable for modeling these problems due to their ability to capture the uncertainty associated with the outcome of the treatment and the stochastic nature of the underlying process. The RL algorithm employed in the proposed methodology is fitted Q iteration, which stands out for its ability to make an efficient use of data. Results: The experiments reported here are based on a computational model that describes the effect of ESAs on the hemoglobin level. The performance of the proposed method is evaluated and compared with the well-known Q-learning algorithm and with a standard protocol. Simulation results show that the performance of Q-learning is substantially lower than FQI and the protocol. Conclusion: Although prospective validation is required, promising results demonstrate the potential of RL to become an alternative to current protocols.